Total Ankle Replacement Outcomes in Obese Patients with Minimum 10-Year Follow-Up

Background: Obesity rates continue to rise worldwide. Current evidence for total ankle replacement (TAR) in obese patients is conflicting, limited to short-term to mid-term follow-up. Therefore, the aim of this study was to assess long-term outcomes of obese versus nonobese TAR patients. Methods: ): ≥30 (obese) or <30 (nonobese). Primary outcome measures included the Ankle Osteoarthritis Scale (AOS) and Short-Form 36 (SF-36). Secondary outcomes described secondary procedures following TAR. Multivariable linear regression was completed for patient-reported outcomes measures (PROMs). Results: The study included 515 TARs in 482 patients (236 ankles obese, 279 ankles nonobese) with a mean age of 64 years and mean follow-up of 13.2 years. 310 TARs had minimum 10-year PROMs follow-up for analysis. No statistically significant differences in AOS pain/disability and SF-36 Physical Component Summary/Mental Component Summary changes scores (preoperative to latest follow-up) were observed between the 2 cohorts. Obese patients had statistically worse AOS disability scores preoperatively (p = 0.01), while disability levels were comparable postoperatively. Multivariable linear regression analysis revealed BMI ≥30 was not associated with poorer outcomes when adjusting for age, sex, implant, preoperative PROM score, follow-up duration, arthritis etiology, or diabetes. The number of patients undergoing secondary procedures and the number of secondary procedures required between cohorts were similar (34.4% obese TARs vs. 37.6% nonobese TARs). Conclusions: TARs can be successfully undertaken in obese patients with long-term improvement in PROMs and no significant increase in incidence of secondary procedures similar to their nonobese counterparts. These findings challenge the perception of obesity as a relative contraindication to TAR and support its use in appropriately selected obese patients. Level of Evidence: Level III. See Instructions for Authors for a complete description of levels of evidence.

Authors

Institutions

Publication Details

Journal
JBJS Open Access
Published
2026-04-01
DOI
https://doi.org/10.2106/jbjs.oa.26.00054
Primary Topic
Foot and Ankle Surgery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Total Ankle Replacement Outcomes in Obese Patients with Minimum 10-Year Follow-Up

Ellie Pinsker, Kashaf Fayyaz, Mansur Halai, Zakir Haider et al.
JBJS Open Access
Foot and Ankle Surgery
article

Total Ankle Replacement Outcomes in Obese Patients with Minimum 10-Year Follow-Up

Ellie Pinsker, Kashaf Fayyaz, Mansur Halai, Zakir Haider, Ryan Khan, Timothy Daniels
article en

Abstract

Background: Obesity rates continue to rise worldwide. Current evidence for total ankle replacement (TAR) in obese patients is conflicting, limited to short-term to mid-term follow-up. Therefore, the aim of this study was to assess long-term outcomes of obese versus nonobese TAR patients. Methods: ): ≥30 (obese) or <30 (nonobese). Primary outcome measures included the Ankle Osteoarthritis Scale (AOS) and Short-Form 36 (SF-36). Secondary outcomes described secondary procedures following TAR. Multivariable linear regression was completed for patient-reported outcomes measures (PROMs). Results: The study included 515 TARs in 482 patients (236 ankles obese, 279 ankles nonobese) with a mean age of 64 years and mean follow-up of 13.2 years. 310 TARs had minimum 10-year PROMs follow-up for analysis. No statistically significant differences in AOS pain/disability and SF-36 Physical Component Summary/Mental Component Summary changes scores (preoperative to latest follow-up) were observed between the 2 cohorts. Obese patients had statistically worse AOS disability scores preoperatively (p = 0.01), while disability levels were comparable postoperatively. Multivariable linear regression analysis revealed BMI ≥30 was not associated with poorer outcomes when adjusting for age, sex, implant, preoperative PROM score, follow-up duration, arthritis etiology, or diabetes. The number of patients undergoing secondary procedures and the number of secondary procedures required between cohorts were similar (34.4% obese TARs vs. 37.6% nonobese TARs). Conclusions: TARs can be successfully undertaken in obese patients with long-term improvement in PROMs and no significant increase in incidence of secondary procedures similar to their nonobese counterparts. These findings challenge the perception of obesity as a relative contraindication to TAR and support its use in appropriately selected obese patients. Level of Evidence: Level III. See Instructions for Authors for a complete description of levels of evidence.

JBJS Open AccessVol. 11(2)
St. Michael's Hospital (CA), St Michael’s Hospital (IE)
Zero hunger
Openalex Percentile: Top 24%
Foot and Ankle Surgery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.